ACADIA Pharmaceuticals Inc.

ACAD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$257,996$253,637$217,696$319,589
Short-Term Investments$589,023$508,359$463,881$436,404
Receivables$139,438$119,686$113,714$104,695
Inventory$29,097$26,124$22,948$21,949
Other Curr. Assets$60,868$52,747$52,703$55,681
Total Curr. Assets$1,076,422$960,553$870,942$938,318
Property Plant & Equip (Net)$53,381$54,538$54,112$50,786
Goodwill$0$0$0$0
Intangibles$111,615$114,338$117,060$119,782
Long-Term Investments$9,471$9,471$0$0
Tax Assets$0$0$0$0
Other NC Assets$79,882$86,655$90,250$78,870
Total NC Assets$254,349$265,002$261,422$249,438
Other Assets$0$0$0$0
Total Assets$1,330,771$1,225,555$1,132,364$1,187,756
Liabilities
Payables$21,747$20,097$18,095$16,192
Short-Term Debt$11,783$11,693$11,372$9,958
Tax Payable$0$0$9,048$12,016
Deferred Revenue$0$0$0$0
Other Curr. Liab.$323,054$298,234$264,015$356,704
Total Curr. Liab.$356,584$330,024$302,530$394,870
LT Debt$43,026$44,601$44,634$42,037
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$13,889$28,548$19,963$18,056
Total NC Liab.$56,915$73,149$64,597$60,093
Other Liabilities$0$0$0$0
Cap. Leases$43,026$44,601$56,006$51,995
Total Liabilities$413,499$403,173$367,127$454,963
Equity
Pref Stock$0$0$0$0
Common Stock$16$16$16$16
Retained Earnings-$2,086,954-$2,158,733-$2,185,399-$2,204,386
AOCI$989$406$437$292
Other Equity$3,003,221$2,980,693$2,950,183$2,936,871
Total Equity$917,272$822,382$765,237$732,793
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,330,771$1,225,555$1,132,364$1,187,756
Net Debt-$203,187-$197,343-$161,690-$267,594
ACADIA Pharmaceuticals Inc. (ACAD) Financial Statements & Key Stats | AlphaPilot